CJ Corp.

Korea: Hyundai Heavy wins back oil unit.
TendersInfo; 11/16/2009; 1022 words; ...diversify its business. Last year it bought CJ Investment and Securities, now known as...selected as a preferred bidder for Hyundai Corp. Hyundai Heavy will keep its top position...Securities. The final contract for the Hyundai Corp. acquisition is expected to be signed by...

BioTime CEO Dr. Michael West to Present at Stem Cells USA & Regenerative Medicine Congress 2009.
Business Wire; 11/12/2009; 999 words; ...blood plasma volume expander manufactured and distributed in the U.S. by Hospira, Inc. and in South Korea by CJ CheilJedang Corp. under exclusive licensing agreements. Additional information about BioTime can be found on the web at www.biotimeinc...

Chief Medical Officer of BioTime's Subsidiary OncoCyte Corporation to Deliver Keynote Address at Fifth Chinese Congress on Stem Cell Therapy in Beijing, P.R. China.
Angiogenesis Weekly; 11/6/2009; 1283 words; ...blood plasma volume expander manufactured and distributed in the U.S. by Hospira, Inc. and in South Korea by CJ CheilJedang Corp. under exclusive licensing agreements. Additional information about BioTime can be found on the web at www.biotimeinc...

Other News To Note.
BIOWORLD Today; 11/4/2009; 2638 words; ...Berkeley, Calif., granted to CJ Corp., of Seoul, South Korea...human therapeutic uses. CJ will be responsible for obtaining...related costs and expenses. CJ has right of first refusal...sales royalties. o Cambrex Corp., East Rutherford, N...

Publication No. WO/2009/091228 Published on July 23, Assigned to Cj Cheiljedang for Guanosine Monophosphate Kinase Variant (South Korean Inventors)
US Fed News Service, Including US State News; 10/31/2009; 417 words; ...a guanosine monophosphate kinase variant having reduced gmp conversion activity. The patent has been assigned to Cj Cheiljedang Corp., Seoul, South Korea. According to an abstract posted by the World Intellectual Property Organization: "The...